Coresh J - Search Results

1

Kidney function estimating equations: where do we stand?

Coresh J, Stevens LA. Coresh J, et al. Curr Opin Nephrol Hypertens. 2006 May;15(3):276-84. doi: 10.1097/01.mnh.0000222695.84464.61. Curr Opin Nephrol Hypertens. 2006. PMID: 16609295 Review.

2

Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis.

Coresh J, Walser M, Hill S. Coresh J, et al. J Am Soc Nephrol. 1995 Nov;6(5):1379-85. doi: 10.1681/ASN.V651379. J Am Soc Nephrol. 1995. PMID: 8589312

3

Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

Toto RD, Kirk KA, Coresh J, Jones C, Appel L, Wright J, Campese V, Olutade B, Agodoa L. Toto RD, et al. Among authors: coresh j. J Am Soc Nephrol. 1997 Feb;8(2):279-87. doi: 10.1681/ASN.V82279. J Am Soc Nephrol. 1997. PMID: 9048347

4

Further trends in the etiology of end-stage renal disease in African-Americans.

Coresh J, Jaar B. Coresh J, et al. Curr Opin Nephrol Hypertens. 1997 May;6(3):243-9. doi: 10.1097/00041552-199705000-00008. Curr Opin Nephrol Hypertens. 1997. PMID: 9263667 Review.

5

Familial aggregation of renal disease in a population-based case-control study.

Lei HH, Perneger TV, Klag MJ, Whelton PK, Coresh J. Lei HH, et al. Among authors: coresh j. J Am Soc Nephrol. 1998 Jul;9(7):1270-6. doi: 10.1681/ASN.V971270. J Am Soc Nephrol. 1998. PMID: 9644638

6

Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study.

Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, Agodoa L, Van Lente F. Coresh J, et al. Am J Kidney Dis. 1998 Jul;32(1):32-42. doi: 10.1053/ajkd.1998.v32.pm9669421. Am J Kidney Dis. 1998. PMID: 9669421 Clinical Trial.

7

Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease.

Daumit GL, Hermann JA, Coresh J, Powe NR. Daumit GL, et al. Among authors: coresh j. Ann Intern Med. 1999 Feb 2;130(3):173-82. doi: 10.7326/0003-4819-130-3-199902020-00002. Ann Intern Med. 1999. PMID: 10049195

8

A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study.

Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, Szklo M, Brancati FL. Krop JS, et al. Among authors: coresh j. Arch Intern Med. 1999 Aug 9-23;159(15):1777-83. doi: 10.1001/archinte.159.15.1777. Arch Intern Med. 1999. PMID: 10448782

9

Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.

Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR. Longenecker JC, et al. Among authors: coresh j. J Am Soc Nephrol. 2000 Mar;11(3):520-529. doi: 10.1681/ASN.V113520. J Am Soc Nephrol. 2000. PMID: 10703676

10

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Muntner P, et al. Among authors: coresh j. Kidney Int. 2000 Jul;58(1):293-301. doi: 10.1046/j.1523-1755.2000.00165.x. Kidney Int. 2000. PMID: 10886574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results